Susan Bobulsky, SVP, Diagnostics, clono SEQ at Adaptive Biotechnologies Corp (ADPT), sold 25,000 shares at $55.00 ($1.4M) on 2020-12-10, disclosed to the SEC on 2020-12-11.
Open-market sale of $1.4M ADPT by SVP, Diagnostics, clono SEQ. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ADPT | SELL | 2026-08-12 | $75K | — | Filing → |
| ADPT | SELL | 2026-08-03 | $31K | — | Filing → |
| ADPT | SELL | 2026-07-20 | $115K | — | Filing → |